Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEPALI Study of nebulized heparin in mechanically ventilated patients with acute lung injury or acute respiratory distress syndrome
NL-OMON28056Recruiting
- Sponsor
- Self funding research.
- Start
- Jan 2008
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) comparing Nebulized heparin with Placebo (2 arms). Primary endpoints: Thrombin-antithrombin complexes in bronchoalveolar lavage fluid and Pulmonary leak index. Started Jan 2008; status: recruiting.
02
Drugs
heparin
03
Conditions
acute lung injury (ALI)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NL-OMON28056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28056.